Same price per vial — no bulk discount, just add more to one order.
20% off included — code WELCOME20 is reflected in this price and applied automatically at checkout.
For laboratory research use only · Not for human consumption · Read handling terms →
Third-party HPLC, mass-spec, and endotoxin testing on every batch — with the Certificate of Analysis included, not on request.
Ipamorelin is a selective pentapeptide ghrelin-receptor agonist studied for its targeted stimulation of growth-hormone release with minimal effect on other hormones. That selectivity, with comparatively little impact on cortisol or prolactin, makes it a common reference compound in secretagogue research.
Developed by Novo Nordisk under the code NNC 26-0161 and derived from GHRP-1, ipamorelin was characterized in the late 1990s as one of the most selective growth-hormone secretagogues then known. Its clean selectivity profile, releasing growth hormone with limited off-target hormonal activity, is what distinguished it from earlier secretagogues in experimental models.
Ipamorelin has been studied in endocrine models for selective growth-hormone-secretagogue-receptor agonism, growth-hormone-pulse stimulation, and IGF-1 modulation. Its selectivity is the central research feature: it allows investigators to stimulate growth-hormone output while holding other endocrine variables relatively steady, which simplifies interpretation. As a defined and highly selective secretagogue, it functions as a clean comparator in studies of secretory signaling.
Same-day dispatch before 2:00 PM CST, Monday through Saturday. Store lyophilized vials at −20°C, protected from light; reconstituted solutions at 2–8°C. Discreet, temperature-safe packaging. Guaranteed delivery with free reshipment.
Most researchers don’t ask. The ones who do, switch.
Reach out and get a response within minutes.
CJC-1295 + Ipamorelin · 10mg — $89.00More in SecretagogueView
Sermorelin · 5mg — $49.00More in SecretagogueView